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Abstract-By using metabolic control theory we show how one can calculate the effect 
on steady-state metabolite concentrations and steady-state fluxes of small amounts of 
inhibitors or activators of individual enzymes in a metabolic system of arbitrary com- 
plexity. It turns out that only limited knowledge of the kinetics of the enzymes in the 
systems, summarized in their “Elasticity Coefficients,” is needed. An example of an 
actual calculation is given. 
INTRODUCTION 
Decades of extensive biochemical research have led to an enormous increase in our un- 
derstanding of metabolism in living systems, including man. This is witnessed by the 
availability of metabolic maps of all major biosynthetic and biodegradative pathways and 
the rather detailed description of the kinetic properties of important enzymes. Paradox- 
ically, this increasing success has been accompanied by a widening schism between bio- 
chemistry and medicine. Although acclaiming the achievements of biochemists, more 
clinically oriented researchers increasingly doubt the relevance of detailed knowledge of 
enzymes for the understanding of how the complex assemblies of multitudes of enzymes 
function in the human body. For instance, even if the mechanism of action of a given 
(toxic or therapeutic) agent is known at the level of the isolated enzymes, it is still im- 
possible to predict its effect on the metabolism of an entire cell, because (i) it is not known 
how the fluxes through the metab,olic pathways depend on the activity of the target en- 
zyme; (ii) the agent may have (“side”) effects on other enzymes; (iii) the primary effect 
of the agent may cause metabolic alterations (the concentrations of certain metabolites, 
or metabolic modifiers may change) that also affect the metabolic fluxes. 
Another example of the gap between biochemistry and medicine is in those medical 
diagnoses where, from a number of measured changes in metabolite concentrations, the 
clinician must conclude which enzymic activities may be faulty. Again, for metabolic 
systems of any complexity the relationship between steady-state metabolite concentra- 
tions (or metabolic fluxes) and enzymic properties is insufflciently understood for a ra- 
tional diagnosis. Instead, experience with “common cases” has to direct the physician 
to what may be wrong with the patient. 
Much work is being done to bridge this gap between biochemistry and medicine. One 
approach is to detect empirical relationships between (toxic or therapeutic) agents and 
metabolic changes (e.g.[l]). Although clinically important, this approach is unsatisfactory 
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in that it leaves our vast biochemical knowledge essentially infertile. In another approach 
(e.g.[2,3]) the kinetic rate laws of all enzymes in a metabolic system are fed into acomputer 
and the computer is programmed to give the steady-state fluxes and metabolite concen- 
trations at desired experimental conditions. This approach has the limitations that it re- 
quires large computer capacities, as well as nearly complete knowledge of the kinetic 
characteristics of all the enzymes in the metabolic systems. 
Two developments have prompted us to investigate if, in a large number of cases, the 
abyss between the clinical questions and the biochemical knowledge could not be bridged 
by a relatively simple “biomathematical” procedure. The first was the elaboration of a 
theory for the control of metabolic fluxes[ct-IO], metabolite concentrations and membrane 
potentials[ll, 121. By use of this theory (reviewed in [ 13]), the effect of small changes in 
enzyme activities on fluxes and concentrations could be expressed in terms of kinetic 
properties of the enzymes and ratios of metabolic fluxes. 
The second development was that in cancer research, where it was shown (e.g.[141, 
review:[U, 161) that at least in some cases, relatively minor alterations in the activity of 
normal (“onto-“) proteins can lead to cellular transformation. Also other (sometimes 
inheritable) diseases (like some of the lysosomal storage diseases) are the (long-term) 
effect of relatively small alterations in enzyme activities. 
In this paper we demonstrate how the effects of small changes in enzyme activities on 
metabolic fluxes can be predicted for metabolic systems of arbitrary complexity. What 
is needed is knowledge of a rather limited number of kinetic properties of the enzymes 
(their “Elasticity Coefficients”; see Refs. [6-121 and below) and the relative magnitudes 
of the metabolic fluxes. We shall also show how the effects of small doses of (toxic or 
therapeutic) agents can be predicted from the above information plus knowledge of their 
biochemical interaction with the individual enzymes. 
THEORY 
Although this paper could also be developed in terms of the “Biochemical System 
Analysis” method[4,5,8, lo], we here choose to develop it in terms of “Metabolic Control 
Theory”[6, 7, 9, 11-13, 171. Whilst, formally, the latter theory is a subset of the former, 
this subset will be sufficient for our present purpose. Moreover, the theorems that are 
needed in the present paper are most explicit in Metabolic Control Theory. 
The control exerted by enzyme Ej on the concentration of metabolite 121,, which in 
the recently agreed new terminology[l7] will be called the Control Coefficient of [M,] 
with respect to Ei, is defined by (cf.[6, 131) 
[Eil dlMm1 cj$.fm’ = - . - 
[Mm1 d[Eil ’ 
Throughout this paper we shall use d’s to refer to (partial) differentials of steady-state 
properties. The Elasticity Coefficient of the reaction catalyzed by enzyme Ei with respect 
to metabolite ltlk is defined as (cf. [6, 13, 171) 
(2) 
where vi is the (net) reaction rate through enzyme Ei. In the following the Metabolite- 
Concentration-Control Coefficient C.g<m and the Elasticity Coefficient E&I will occasion- 
ally be abbreviated by CT and ei, respectively. 
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The Concentration-Control Coefficient of a metabolite iv,,, with respect to an enzyme 
E;, i.e. CT, is a measure of the relative change in concentration of metabolite _V,,, occurring 
if the concentration of enzyme Ei is increased, whilst the concentrations of the other 
enzymes in the system are kept constant. It is not the immediate change in the metabolite 
concentration that is implied, but the change in concentration from its initial value to the 
value it attains after the system has relaxed towards a new steady state. The concentrations 
of other metabolites may have changed as well. By dividing the relative change in me- 
tabolite concentration by the relative change in enzyme concentration, a measure is ob- 
tained for the importance of the enzyme Ei in the determination of the metabolite con- 
centration [/cl,,,]. Unless the relative change in enzyme concentration were small, this 
ratio would depend on the magnitude of that relative change. Therefore. the changes are 
taken to be infinitesimally small in the definitions of Control Coefficients (and of Elasticity 
Coefficients). 
Whereas the Metabolite-Concentration- (or Flux-) Control Coefficients with respect to 
enzymes are properties of the metabolic system as a whole, the Elasticity Coefficients 
are properties of the individual enzymes. The Elasticity Coefficients quantify the extent 
to which the rate of an enzymic reaction responds to changes in the concentrations of its 
substrates or effecters. Here one considers the effect of a change in the concentration of 
one metabolite on the enzymic rate at constant concentrations of the other metabolites 
(i.e. one does not allow the adjustment of the latter concentrations to a new steady state: 
one essentially perform an initial rate measurement). In principle the Elasticity Coefficient 
can be calculated if the kinetics of the enzyme (and the metabolite concentrations) are 
known. Also, direct experimental measurement of the Elasticity Coefficient according to 
its definition, is feasible. 
In a metabolic system with N enzymes and Q metabolites there are :N.Q Elasticity 
Coefficients E$, (if,, in short), N.Q Metabolite-Concentration-Control Coefficients by 
enzymes Cz- (Cy in short) and N reaction rates ~1;. Metabolites participate in reactions, 
but not in all reactions to the same extent. This may be indicated by Coefficients CX?),, 
(CL& in short). CXF would be 1 if metabolite !LI,,, is the product of reaction i at a stoichiometry 
of 1 per turnover. a$ would be -2 if reaction i consumes two molecules of M, per 
turnover. Matrices E, C, (Y, and v can now be defined by eqns (3)-(6), respectively: 
c; c; ‘.. CL 
c = c: c; .‘. c’, l i . . ,.. . ’ cp c” ‘.. c% 
al cc; ... cxh 
oL= 
a; &; . . . a& l ‘r . . . . . . ’ CY; (-$ . . . &$ 
t’l 0 ... 0 
0 1’1 .’ 0 0 
v= 
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In the steady state the net rate of formation of any metabolite M,,, vanishes[9]: 
N 
2 a’,.& = v . - = 4Mnl o 
i= I dt ’ 
(7) 
Here V is the volume of the compartment M, is in (in liters). Also the change in this 
steady-state formation rate resulting from any change in concentration of any enzyme E,, 
must be zero[6]. Hence for any combination of enzyme E, and metabolite M,: 
There are Q sets (one for each metabolite) of N equations (one for each enzyme) in Q.N 
unknowns (the Concentration-Control Coefficients). These N.Q linear equations allow 
the expression of the Metabolite-Concentration-Control Coefficients into the Elasticity 
Coefficients and the ratios between the different steady-state reaction rates. To this pur- 
pose we rewrite them in matrix notation: 
OQiv = cY**v + c!fT*V*E~C. (9) 
Here 01~ is the transpose of matrix 0~. OQN is a Q.N zero matrix. To solve this equation 
for C, we note that the matrix S defined by 
s = oLTTf (10) 
is square (Q-Q) so that its inverse S-i may exist. In the applications promoted here, it 
will sufftce to just calculate the determinant of matrix S and establish whether it is nonzero. 
In the usual case where it is nonzero, the matrix is nonsingular, S-’ exists, and the 
algorithm presented below can be used. The singularity of S is related to local instability 
of the system. However, this topic goes beyond the purposes of the present paper. For 
further discussion of this topic we refer the reader to Ref. [8]. From here on in this paper, 
we shall assume that S- ’ exists. We now multiply eqn (9) from the left with S-‘, which 
yields 
C = -S-1.aT.v. (11) 
According to its definition the element Cgm.d ln[Ei] gives the relative change in con- 
centration of metabolite M, when the activity of enzyme i is changed by the infinitesimally 
small fraction d ln[Ei]. If we want to know the accompanying relative change in metabolic 
flux J, we consider the rate vk of any reaction through which J flows and write the relative 
change in vk (i.e. J) as a function of the relative changes in the steady-state concentrations 
of all metabolites that affect Vk: 
d In ) vk 1 = d h[Ekl + 2 dij d ln[M~l. (12) 
We stress that EK denotes the total concentration of enzyme k. As a result: 
cut = d In 1 vk 1 
Et d ln[Ei] 
= si + 2 ,ffjC$ (13) 
Here 8: is the Kronecker delta; i.e. equal to 1 if i = k, otherwise equal to zero. In fact, 
Steady-state fluxes and concentrations in metabolic skstsms 1177 
the Flux-Control Coefficient Cg [6. 13, 173 is equal to the (X-, i) element of the N./V matrix 
EC + 1: 
c:” = (EC)kj + s; = (EC + l)i,. ill) 
1 is a unity matrix. 
The effect of a given agent I on an enzyme Ei may be quantified as 
i.e. the relative change in reaction rate ~1; divided by the change in the concentration [I] 
of that agent at constant concentrations of all other metabolites. It may be noted that this 
8 is related to, yet different from, an Elasticity Coefficient. The reason for defining 13 is 
that we wish to investigate the effect of an addition of a small amount of inhibitor I to a 
system that does not yet contain I. This zeroness of [I] makes the Elasticity Coefficient 
of the inhibited enzyme with respect to I equal to zero. For the mathematical analysis to 
follow it is therefore simpler to work with the related quantity 0, defined in eqn (15). Or 
may be written as a column vector, comparable to a column of e. Using eqns (I), (IO), 
(1 I), and (14), the effect of a small amount of agent I on the concentration of metabolite 
M,,, is given by 
ci”m = d MM,1 
d[ll 
= (a,), = -((a=.V.f)-‘.OLT.v.e,)m. 
Similarly, the effect of I on flux J is (using eqns (12) and (16)): 
czsk = d ln I vk I 
I 
d[ll 
= (1 + ECfl[)k = -(l + E.(OLT.v.E)-‘.OL=.v.e~)~ (171 
E contains the (only essential) kinetic properties of the enzymes, OL contains the infor- 
mation concerning the metabolic map, v contains the actual metabolic fluxes, and 8 con- 
tains the effects of the agent I on the individual enzymes. Hence eqn (17) gives the effect 
of a little bit of agent I on the metabolic flux vx-, calculated only from the essential aspects 
(E) of the kinetic properties of the enzymes, the metabolic map (a) and the existing mag- 
nitudes of the flux (v): the equation links the medical question of what the effect of agent 
I is, to the biochemical knowledge of the metabolic system. Although eqn (17) may seem 
complex, it is readily solved by small computers. 
EXEMPLARY APPLICATION 
As an example, we consider the metabolic pathway depicted in Fig. 1. The concen- 
trations of the pathway substrate S and the pathway product P are constant (this is nec- 
essary to obtain steady states). The concentrations of the metabolites MI, Mz, M3, and 
M1 can vary from one steady state to another. The information concerning the “structure” 
of the metabolic pathway is contained in matrix a. Since M, is the product of reaction 1 
and only one molecule of MI is formed per turnover of reaction 1, a! = 1. Reaction 1 
consumes M, at a stoichiometry of 1. Hence (Y) = - 1. Reaction 5 consumes nor produces 
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P 
Fig. 1. Exemplary metabolic pathway with metabolites M,. enzymes Ei, pathway substrate S. and pathway 
product P. 
Mi: CY: = 0. The complete 01 matrix is 
1 0 0 0 
-1 0 0 1 
-1 1 0 0 01= 
: I O-l IO' 0 o-1 1 0 0 0 -1 
The matrix of Elasticity Coefficients (E) contains all the information as to how the enzymes 
respond to changes in metabolite concentrations. In our example a 1% increase in the 
concentration of Mz, at constant concentrations of all the other metabolites, is taken to 
cause an increase in v4 by 0.4% (E 2 = 0.4), a decrease in u3 by 0.2% (ES = -0.2) and to 
be without effect on vI, u2, v5, and z/6 (E: = E: = E: = E$ = 0). It may be noted that the 
pathway exhibits feedback inhibition: E: is negative and M4 is not a substrate nor a product 
of Ei. Enzymes 2, 3, 4, 5, and 6 are taken to be responsive to their own substrates and 
products only. The complete E matrix is 
E= 
-0.2 0 0 -0.1 
0.5 0 0 -0.4 
0.3 -0.2 0 0 
0 0.4 -0.6 0 
0 0 0.8 -0.4 
0 0 0 0.2 
In our example we take the steady-state reaction rates before the addition of agent Z to 
be given by 
300000 
020000 
“,_001000 - 1 I 000100’ 000010 000003 
It may be checked that u3 = u4 = u5 and that u2 + v5 = vg. We assume that one unit of 
added agent Z decreases the activity of enzyme 2 by 1% and has no direct effect on any 
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other enzyme. Hence 
eT = (0 -0.01 0 0 0 0). 
Having thus defined the essential properties of the metabolic pathway and the agent 
I, we turn to the question of the steady-state effect of, say, 5 units of I on the concentration 
of metabolite 2 and on the flux through enzyme 6. To answer this question, we employed 
our computer to evaluate CiW (from eqn (16)) and C;’ (from eqn (17)). The result was 
(CM)= = (0.0093 0.0040 - 0.0062 - 0.00062), 
(CT)’ = (-0.0012 -0.0029 0.0020 0.0020 0.0020 -0.0012). 
These numbers indicate the percentage changes of M, , Mz, . . . , and ifI. tl,, . . . , etc.. 
on the addition of one unit of I. For example, one unit of I would increase A42 by 0.4% 
and decrease Mj by 0.62%. Consequently, 5 units of Z would cause Mz to increase by 
approximately 2%. By inspecting the sixth element of Cy we found that 5 units of Z would 
decrease t’g by some 0.62%. 
The results in this example warrant some further discussion. The second element of 
vector C;’ demonstrates that inhibition of enzyme 2 would decrease the reaction rate 
through enzyme 2, which is, of course, expected. The first element of C;’ shows that. 
although to a lesser extent, the reaction rate through E, is also diminished. This is un- 
derstandable, because [MI] increases (cf. the first element in vector C>‘) and reac?ion I 
is subject to product inhibition (E I = - 0 2 hence negative). The effect that [Md] decreases 
(cf. fourth element of Cy”, and that therefore E, is less inhibited by Mq, such that ifI would 
tend to increase loses (i.e. 0.00062.0.1 < 0.0093.0.2) both because the change in [M,] is 
smaller than the change in [MI] and because minus the Elasticity Coefficient of enzyme 
1 with respect to M, is smaller than that with respect to MI. 
The increase in [M,] causes an increase in ‘u3, uq, and 11~. Thus, inhibition of Ez causes 
more flow to go through the shunt pathway through E3, Ed, and Es. Yet, the total flou 
(through El, or E6) is reduced due to inhibition of El. It is of some interest to note that 
inhibition of E, causes a “crossover” to occur not only between MI and Mz, but also 
between Mz and M3 (i.e. [Mz] increases whilst [M3] decreases). Clearly. the occurrence 
of a crossover at a given enzyme (e.g. here E4) does not necessarily prove that the inhibitor 
acts at that enzyme (cf. [ 11, 181). That [Mz] increases and [M3] decreases whilst ~3, 11~. 
and u5 all increase, may seem a bit counterintuitive. One might argue that, for a rate to 
increase, the concentration of the substrate should increase and that hence [MJ] should 
increase for u5 to increase. However, due to the strong reduction in ul, [AG] decreases 
(cf. the last element in C,“) and since u5 is strongly product inhibited by [Md] (E: = 0.4) 
this is the cause of an increase in u5 upon inhibition of Ez. This strong increase in ~‘5 then 
lowers [Mxl. It will be clear that the present discussion refers to this specific example 
only. However, with the above algorithm, it will be simple to evaluate and discuss other 
examples. 
DISCUSSION 
In this paper we have illustrated how biochemical knowledge of a metabolic pathway. 
metabolic control theory, and the computer’s ability to multiply and invert matrices, can 
be combined to predict effects of small additions of agents on steady-state fluxes and 
metabolite concentrations. That the possibility of such predictions depends on the knowl- 
edge of the kinetics of the enzymes in the system, is of course an inescapable phenomenon. 
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However, the present approach shows that only relatively little information about the 
kinetics is needed: the responsiveness (here used in the everyday sense) of the enzymes 
towards changes in metabolite concentrations (quantified by the E’S, i.e. the so-called 
Elasticity Coefficient[I7]). 
In principle, the present method is limited to infinitesimally small amounts of added 
agent I. If actual additions are large, then results from the type of calculation presented 
here cannot be more than a first order approximation. For better estimations of the effects 
of large amounts of agent I, one shall need other theories (e.g. as described in Refs. [2, 
3, 5, 121). Perhaps Biochemical Systems Analysis[4, 5, 8, lo] is the most natural extension 
of the Metabolic Control Theory used here, to cases where large amounts are added. In 
systems where thermodynamic parameters are studied, the Nonequilibrium Thermody- 
namic methods may be useful[l2]. In all these cases of larger amounts, more information 
about the system is needed than for the present analysis of the effect of additions of small 
amounts. 
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